Is Vitrafy Life Sciences Ltd. overvalued?

Vitrafy Life Sciences Ltd. (VFY.AX) — key valuation metrics and fundamentals.

No verdict

Price

$3.01

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$226.9M

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares VFY.AX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.

Related stocks